import streamlit as st
import google.generativeai as genai
import pandas as pd

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æ¥µé‡åŒ–å°ˆæ¥­ç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

# åˆå§‹åŒ– session_state
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = "ğŸ“š RUBY (ENGOT-EN6)"

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9; color: #1A1A1A;
        font-size: 18px !important;
    }

    .main-title {
        font-size: 38px !important; font-weight: 900; color: #004D40;
        padding: 15px 0; border-bottom: 5px solid #004D40; margin-bottom: 15px;
    }

    /* å¼·åŒ–å°ˆå±¬æ¨™ç±¤ï¼šDUO ç³»åˆ—èˆ‡æ——è‰¦è©¦é©— */
    .flagship-badge {
        background: #D32F2F; color: white; padding: 2px 8px; border-radius: 4px;
        font-size: 12px; font-weight: 900; margin-right: 5px; vertical-align: middle;
    }

    .big-stage-card {
        border-radius: 12px; margin-bottom: 10px; overflow: hidden;
        box-shadow: 0 4px 15px rgba(0,0,0,0.1); background: white;
    }
    .big-stage-header {
        font-size: 22px !important; font-weight: 900; color: white !important;
        padding: 15px; text-align: center;
    }

    /* éšæ®µé…è‰² */
    .card-p-tx { border: 2px solid #2E7D32; } .header-p-tx { background: #2E7D32; }
    .card-p-mt { border: 2px solid #1565C0; } .header-p-mt { background: #1565C0; }
    .card-r-tx { border: 2px solid #C62828; } .header-r-tx { background: #C62828; }
    .card-r-mt { border: 2px solid #6A1B9A; } .header-r-mt { background: #6A1B9A; }

    .sub-block {
        margin: 10px; padding: 12px; border-radius: 8px; background: #F8F9FA;
        border-left: 5px solid #455A64;
    }
    .sub-block-title { font-weight: 900; color: #263238; font-size: 18px; margin-bottom: 5px; }

    /* æŒ‰éˆ•å¼·åŒ– */
    .stPopover button { 
        font-weight: 900 !important; color: #1A1A1A !important;
        border: 2px solid #BDBDBD !important; transition: 0.3s;
    }
    .stPopover button:hover { border-color: #004D40 !important; background: #E0F2F1 !important; }

    /* æ·±åº¦çœ‹æ¿å€ */
    .detail-section { background: white; border-radius: 15px; padding: 30px; border: 1px solid #CFD8DC; box-shadow: 0 10px 30px rgba(0,0,0,0.05); }
    .regimen-box { 
        background: #E8F5E9; border-left: 8px solid #2E7D32; padding: 20px; 
        border-radius: 10px; font-size: 17px; line-height: 1.6; font-family: 'Roboto Mono', monospace;
    }
    .hr-big-val { font-size: 32px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- æ•¸æ“šåº«ï¼šç´å…¥ DUO-O ä¸¦æ¨™è¨˜ Flagship ---
all_trials_db = [
    # === Endometrial ===
    {
        "cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H / MMRd"], 
        "name": "ğŸ“š RUBY (ENGOT-EN6)", "pharma": "GSK", "drug": "Dostarlimab + Carbo/Pacli", 
        "flagship": False,
        "regimen": """<b>1. èª˜å°æœŸ (Induction):</b> Dostarlimab 500 mg IV Q3W + Carboplatin (AUC 5) + Paclitaxel (175 mg/mÂ²) å…± 6 å€‹é€±æœŸã€‚<br>
                      <b>2. ç¶­æŒæœŸ (Maintenance):</b> Dostarlimab 1000 mg IV Q6Wï¼ŒæŒçºŒçµ¦è—¥ç›´åˆ° 3 å¹´æˆ–ç–¾ç—…é€²å±•ã€‚""",
        "outcomes": "dMMR PFS HR 0.28 (0.16-0.50); mOS æœªé”åˆ° vs 18.3m (HR 0.32)",
        "inclusion": ["Stage III/IV æˆ–é¦–æ¬¡å¾©ç™¼ EC", "å¯æ¸¬é‡ç—…ç¶ (RECIST 1.1)", "ECOG 0-1"],
        "exclusion": ["æ›¾ç”¨éå…¨èº«æ€§åŒ–ç™‚ (é™¤å¤–æ–°è¼”åŠ©)", "æ´»å‹•æ€§è‡ªé«”å…ç–«ç–¾ç—…", "éœ€è¦é¡å›ºé†‡æ²»ç™‚çš„é–“è³ªæ€§è‚ºç—…"]
    },
    {
        "cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["pMMR / NSMP / MSS"], 
        "name": "ğŸ”¥ DUO-E (ENGOT-EN9)", "pharma": "AstraZeneca", "drug": "Durvalumab + CP Â± Olaparib", 
        "flagship": True,
        "regimen": """<b>1. èª˜å°æœŸ (Induction):</b> Durvalumab 1120 mg IV Q3W + Carboplatin (AUC 5-6) + Paclitaxel (175 mg/mÂ²) å…± 6 é€±æœŸã€‚<br>
                      <b>2. ç¶­æŒæœŸ (Maintenance):</b> <br>
                      - Arm 2: Durvalumab 1500 mg IV Q4W ç›´åˆ°ç–¾ç—…é€²å±•ã€‚<br>
                      - Arm 3: Durvalumab 1500 mg IV Q4W + Olaparib 300 mg BID (å£æœ) ç›´åˆ°ç–¾ç—…é€²å±•ã€‚""",
        "outcomes": "pMMR (Durva+Ola): PFS HR 0.57 (0.42-0.79); dMMR (Durva): PFS HR 0.42",
        "inclusion": ["æ–°è¨ºæ–· Stage III/IV æˆ–å¾©ç™¼æ€§ EC", "æ‰€æœ‰çµ„ç¹”å­¸åˆ†å‹ (å«è‚‰ç˜¤)", "MMR ç‹€æ…‹å·²çŸ¥"],
        "exclusion": ["å…ˆå‰æ¥å—é IO æ²»ç™‚", "è…¦è½‰ç§»æœªå—æ§è€…", "CTCAE Grade >2 çš„å‰©é¤˜æ¯’æ€§"]
    },
    # === Ovarian ===
    {
        "cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], 
        "name": "ğŸ”¥ DUO-O (ENGOT-ov60)", "pharma": "AstraZeneca", "drug": "Durvalumab + CP + Bev Â± Olaparib", 
        "flagship": True,
        "regimen": """<b>1. èª˜å°æœŸ (Induction):</b> Durvalumab 1120 mg IV Q3W + Carboplatin (AUC 5/6) + Paclitaxel (175 mg/mÂ²) + Bevacizumab 15 mg/kg Q3W (å…± 6 é€±æœŸ)ã€‚<br>
                      <b>2. ç¶­æŒæœŸ (Maintenance):</b> <br>
                      - Durvalumab 1500 mg IV Q4W (æŒçºŒ 24 å€‹æœˆ) + Bevacizumab 15 mg/kg Q3W (æŒçºŒ 15 å€‹æœˆ) + Olaparib 300 mg BID (æŒçºŒ 24 å€‹æœˆ)ã€‚""",
        "outcomes": "Non-tBRCAm HRD(+): PFS HR 0.49 (0.34-0.69); ITT PFS HR 0.63",
        "inclusion": ["æ–°è¨ºæ–· FIGO Stage III-IV é«˜ç´šåˆ¥ä¸Šçš®æ€§åµå·¢ç™Œ", "æ¥å—é PDS æˆ–è¨ˆç•« IDS", "ç„¡ BRCA çªè®Šè€…ç‰¹åˆ¥é—œæ³¨"],
        "exclusion": ["éä¸Šçš®æ€§è…«ç˜¤", "å…ˆå‰æœ‰è…¸æ¢—é˜»ç—…å²", "æ´»å‹•æ€§ç™¼ç‚æ€§è…¸é“ç–¾ç—…"]
    },
    {
        "cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], 
        "name": "ğŸ“š MIRASOL (GOG-3045)", "pharma": "ImmunoGen", "drug": "Mirvetuximab Soravtansine", 
        "flagship": False,
        "regimen": """<b>1. æ²»ç™‚æ–¹æ¡ˆ:</b> Mirvetuximab 6.0 mg/kg (åŸºæ–¼èª¿æ•´å¾Œé«”é‡ AIBW) IV Q3W (æ¯ 21 å¤©ä¸€æ¬¡)ã€‚<br>
                      <b>2. åŠ‘é‡èª¿æ•´:</b> è‹¥ç™¼ç”Ÿè§’è†œç—…è®Š (Keratopathy)ï¼Œæ‡‰æš«åœä¸¦é™éšè‡³ 5.0 mg/kg æˆ– 4.0 mg/kgã€‚""",
        "outcomes": "mOS: 16.4m vs 12.7m (HR 0.67); ORR: 42.3% vs 15.9%",
        "inclusion": ["FRÎ± é«˜è¡¨é” (IHC PS2+ â‰¥ 75%)", "1-3 å‰ç·šæ²»ç™‚æ–¹æ¡ˆ", "é‰‘é¡è€è—¥ (PFI < 6m)"],
        "exclusion": ["æ´»å‹•æ€§è§’è†œç–¾ç—…æˆ–éœ€é•·æœŸé…æˆ´éš±å½¢çœ¼é¡è€…", "æœªæ²»ç™‚çš„ CNS è½‰ç§»"]
    },
    # === Cervical ===
    {
        "cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], 
        "name": "ğŸ“š KEYNOTE-A18", "pharma": "MSD", "drug": "Pembrolizumab + CCRT", 
        "flagship": False,
        "regimen": """<b>1. åŒæ­¥æœŸ:</b> Pembrolizumab 200 mg IV Q3W (å…± 5 åŠ‘) + Cisplatin 40 mg/mÂ² (æ¯é€±ä¸€æ¬¡) + é«”å¤–æ”¾å°„ç·š (EBRT) èˆ‡è¿‘æ¥æ”¾å°„ (Brachytherapy)ã€‚<br>
                      <b>2. ç¶­æŒæœŸ:</b> Pembrolizumab 400 mg IV Q6W (å…± 15 åŠ‘)ã€‚""",
        "outcomes": "36m OS: 82.6% vs 74.8% (HR 0.67); PFS HR 0.70",
        "inclusion": ["æ–°è¨ºæ–· Stage IB2-IIB LN(+) æˆ– Stage III-IVA", "ECOG 0-1", "è‚è…åŠŸèƒ½æ­£å¸¸"],
        "exclusion": ["æ›¾æ¥å—éç›†è…”æ”¾ç™‚", "æ´»å‹•æ€§å…¨èº«å…ç–«ç–¾ç—…"]
    }
]

# --- UI é‚è¼¯ ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 æ¥µé‡åŒ–æ•¸æ“šç‰ˆ)</div>", unsafe_allow_html=True)

cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

# æ¸²æŸ“å°èˆªå¡ç‰‡
import guidelines_data # å‡è¨­æ‚¨å°‡ guidelines_nested ç§»è‡³æ­¤æˆ–ä¿æŒåœ¨åŸè™•
# (ç‚ºäº†ç¸®çŸ­ä»£ç¢¼é•·åº¦ï¼Œæ­¤è™• guidelines_nested å»¶ç”¨æ‚¨åŸæœ¬çš„ dictionary çµæ§‹)
from trial_guidelines import guidelines_nested # ç¤ºæ„

cols = st.columns(4)
for i, stage in enumerate(guidelines_nested[cancer_type]):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div>""", unsafe_allow_html=True)
            
            # éæ¿¾å°æ‡‰è©¦é©—ä¸¦æª¢æŸ¥æ——è‰¦æ¨™è¨˜
            rel_trials = [t for t in all_trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                badge = "<span class='flagship-badge'>ğŸ”¥ FLAGSHIP</span>" if t.get("flagship") else ""
                label = f"{t['name']}"
                with st.popover(f"{badge} {label}", use_container_width=True):
                    st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
                    if st.button("ğŸ“Š åŒæ­¥çœ‹æ¿ç´°ç¯€", key=f"btn_{t['name']}"):
                        st.session_state.selected_trial = t['name']
                        st.rerun()
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- æ·±åº¦çœ‹æ¿ (é€™éƒ¨åˆ†æˆ‘ç‰¹åˆ¥å¼·åŒ–äº†çµ¦è—¥æ–¹æ¡ˆçš„é¡¯ç¤º) ---
st.divider()
selected_trial = next((t for t in all_trials_db if t["name"] == st.session_state.selected_trial), all_trials_db[0])

st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
st.markdown(f"<h2 style='color:#004D40; font-weight:900;'>ğŸ“‹ {selected_trial['name']} æ·±åº¦åˆ†æ (2026 æœ€æ–°æ›´æ–°)</h2>", unsafe_allow_html=True)

r1, r2 = st.columns([1.5, 1])
with r1:
    st.markdown("### ğŸ’‰ è‡¨åºŠçµ¦è—¥æ–¹æ¡ˆ (Precise Regimen Protocol)")
    st.markdown(f"<div class='regimen-box'>{selected_trial['regimen']}</div>", unsafe_allow_html=True)
    
    st.markdown("### âœ… é—œéµç´å…¥æ¨™æº– (Inclusion)")
    for inc in selected_trial['inclusion']: st.write(f"â€¢ {inc}")

with r2:
    st.markdown("### ğŸ“ˆ ç”Ÿå­˜æ•¸æ“šæ‘˜è¦ (Primary Outcomes)")
    st.markdown(f"""
        <div style='background:#FFF8E1; padding:20px; border:2px solid #FFE082; border-radius:15px; text-align:center;'>
            <div style='color:#795548; font-weight:bold;'>Survival Metrics & HR</div>
            <div class='hr-big-val'>{selected_trial['outcomes']}</div>
        </div>
    """, unsafe_allow_html=True)
    
    st.markdown("### âŒ é—œéµæ’é™¤æ¨™æº– (Exclusion)")
    for exc in selected_trial['exclusion']: st.write(f"â€¢ {exc}")

st.markdown("</div>", unsafe_allow_html=True)
